Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia.
Yizhou PengJinjin HuangJin YinFankai MengYang CaoLiang HuangDengju LiYicheng ZhangDonghua ZhangLi MengZhiqiang HanZhenya HongPublished in: Expert review of hematology (2024)
The trial was registered at ClinicalTrials.gov as NCT02690922.
Keyphrases